4//SEC Filing
Viehbacher Christopher 4
Accession 0001127602-25-003962
CIK 0000875045other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:55 PM ET
Size
10.6 KB
Accession
0001127602-25-003962
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Viehbacher Christopher
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2025-02-07$141.35/sh−3,201$452,461→ 12,807 total - Exercise/Conversion
Restricted Stock Unit
2025-02-07−9,008→ 18,017 totalExercise: $0.00Exp: 2027-02-07→ Common Stock (9,008 underlying) - Award
Restricted Stock Unit
2025-02-06+46,360→ 46,360 totalExercise: $0.00Exp: 2028-02-06→ Common Stock (46,360 underlying) - Exercise/Conversion
Common Stock
2025-02-07+9,008→ 16,008 total
Footnotes (2)
- [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.
- [F2]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001774478
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 6:55 PM ET
- Size
- 10.6 KB